[go: up one dir, main page]

AU2013290827B2 - Injectable antibiotic formulations and their methods of use - Google Patents

Injectable antibiotic formulations and their methods of use Download PDF

Info

Publication number
AU2013290827B2
AU2013290827B2 AU2013290827A AU2013290827A AU2013290827B2 AU 2013290827 B2 AU2013290827 B2 AU 2013290827B2 AU 2013290827 A AU2013290827 A AU 2013290827A AU 2013290827 A AU2013290827 A AU 2013290827A AU 2013290827 B2 AU2013290827 B2 AU 2013290827B2
Authority
AU
Australia
Prior art keywords
composition
pnt
pct
penethamate
triacetin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013290827A
Other languages
English (en)
Other versions
AU2013290827A1 (en
Inventor
Fadil Al Alawi
Karthigeyan Nanjan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elanco New Zeeland
Original Assignee
Elanco New Zeeland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49949086&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2013290827(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from NZ613240A external-priority patent/NZ613240B2/en
Application filed by Elanco New Zeeland filed Critical Elanco New Zeeland
Publication of AU2013290827A1 publication Critical patent/AU2013290827A1/en
Application granted granted Critical
Publication of AU2013290827B2 publication Critical patent/AU2013290827B2/en
Assigned to Elanco New Zealand reassignment Elanco New Zealand Request for Assignment Assignors: BAYER NEW ZEALAND LIMITED
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2013290827A 2012-07-17 2013-07-16 Injectable antibiotic formulations and their methods of use Active AU2013290827B2 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
NZ601299 2012-07-17
NZ60129912 2012-07-17
NZ610175 2013-05-03
NZ61017513 2013-05-03
NZ613240A NZ613240B2 (en) 2013-07-12 Injectable antibiotic formulations and their methods of use
NZ613138A NZ613138B2 (en) 2013-07-12 Injectable antibiotic formulations and their methods of use
NZ613138 2013-07-12
NZ613240 2013-07-15
PCT/NZ2013/000124 WO2014014364A1 (fr) 2012-07-17 2013-07-16 Formulations antibiotiques injectables et leurs procédés d'utilisation

Publications (2)

Publication Number Publication Date
AU2013290827A1 AU2013290827A1 (en) 2015-01-15
AU2013290827B2 true AU2013290827B2 (en) 2018-10-18

Family

ID=49949086

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013290827A Active AU2013290827B2 (en) 2012-07-17 2013-07-16 Injectable antibiotic formulations and their methods of use

Country Status (5)

Country Link
US (1) US9452155B2 (fr)
EP (1) EP2874623B1 (fr)
CN (1) CN104507475B (fr)
AU (1) AU2013290827B2 (fr)
WO (1) WO2014014364A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446144A (en) * 1979-05-21 1984-05-01 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Derivatives of penicillanic acid
CN1517090A (zh) * 2003-01-20 2004-08-04 王玉万 含抗菌药物的兽用混悬注射剂或乳剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51516B1 (en) 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
GB2084572B (en) 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IL64009A (en) 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them
IE51846B1 (en) 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
US20060142234A1 (en) 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
US8501800B2 (en) * 2009-03-05 2013-08-06 Insite Vision Incorporated Controlled-release ophthalmic vehicles
WO2013095166A1 (fr) 2011-12-23 2013-06-27 Bayer New Zealand Limited Formulations antibiotiques

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446144A (en) * 1979-05-21 1984-05-01 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Derivatives of penicillanic acid
CN1517090A (zh) * 2003-01-20 2004-08-04 王玉万 含抗菌药物的兽用混悬注射剂或乳剂

Also Published As

Publication number Publication date
EP2874623A1 (fr) 2015-05-27
US20150150854A1 (en) 2015-06-04
AU2013290827A1 (en) 2015-01-15
WO2014014364A1 (fr) 2014-01-23
EP2874623B1 (fr) 2018-12-12
CN104507475A (zh) 2015-04-08
EP2874623A4 (fr) 2016-04-27
CN104507475B (zh) 2019-03-22
US9452155B2 (en) 2016-09-27

Similar Documents

Publication Publication Date Title
AU2016200509B2 (en) Compositions comprising buprenorphine
JP6811270B2 (ja) ランレオチドの持続放出用の医薬組成物
BE1026546A1 (fr) Solution intraveineuse d'acide tranexamique prete a l'emploi
CN112156170B (zh) 可供皮下注射的曲普瑞林缓释微球及其制备方法和用途
JP2015526463A (ja) 改善されたダプトマイシン注射用製剤
AU2013290826B2 (en) Injectable antibiotic formulations and their methods of use
AU2013290827B2 (en) Injectable antibiotic formulations and their methods of use
NZ613138A (en) Injectable antibiotic formulations and their methods of use
NZ613138B2 (en) Injectable antibiotic formulations and their methods of use
NZ613240B2 (en) Injectable antibiotic formulations and their methods of use
TWI631948B (zh) 可注射型抗生素配方及其使用方法
EP2934524B1 (fr) Formulations vétérinaires injectables de pénéthamate
WO2024127418A1 (fr) Compositions injectables de posaconazole
WO2024224424A1 (fr) Compositions injectables de métolazone
Simsek PARENTERAL SUSPENSION: AN OVERVIEW
AU2013364500A1 (en) Veterinary injectable formulations
NZ619101B2 (en) Veterinary Injectable Formulations

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: ELANCO NEW ZEALAND

Free format text: FORMER OWNER(S): BAYER NEW ZEALAND LIMITED